Zymeworks Inc.
ZYME- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937653
No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Zymeworks Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 137 | 1 | 140 | +4 |
| Shares | 63.4M | 228.4K | 62.3M | −860.1K (−1.4%) |
| Value | $547.9M | $1.97M | $395.5M | −$150.5M (−27.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Zymeworks Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (18)
Institutions that held Zymeworks Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Timelo Investment Management Inc. | 185,098 | $1.60M |
| Victory Capital Management Inc | 123,310 | $1.07M |
| Alpha DNA Investment Management LLC | 92,822 | $802.0K |
| Voloridge Investment Management, LLC | 90,803 | $784.5K |
| AE Wealth Management LLC | 63,736 | $550.7K |
| Mach-1 Financial Group, Inc. | 63,736 | $550.7K |
| Brookfield Asset Management Inc. | 63,032 | $544.6K |
| Millennium Management LLC | 55,718 | $481.4K |
| Susquehanna Fundamental Investments, LLC | 31,930 | $275.9K |
| Ritholtz Wealth Management | 22,308 | $192.7K |
| Two Sigma Advisers, LP | 13,200 | $114.0K |
| Coppell Advisory Solutions LLC | 5,661 | $48.3K |
| Cubist Systematic Strategies, LLC | 3,225 | $27.9K |
| Macroview Investment Management LLC | 1,352 | $11.7K |
| Signaturefd, LLC | 450 | $3.89K |
| Psagot Value Holdings Ltd. / (Israel) | 363 | $3.00K |
| IFP Advisors, Inc | 300 | $1.47K |
| Lindbrook Capital, LLC | 35 | $302 |
Not filed for Q3 2023 yet (1)
Institutions that held Zymeworks Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EA Series Trust | 228,373 | $1.97M |